Trial Details
Not RecruitingBasic Information
| Clinical ID | c5137 |
|---|---|
| Identifier | EUCTR2008-002333-75-DE |
| Trial Title | A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT) versus iron sucrose (VENOFER) for treatment of iron deficiency an |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Iron deficiency anaemia in patients with inflammatory bowel disease MedDRA version: 9.1.Level: LLT.Classification code 10055736.Term: Iron deficiency anaemia secondary to blood loss (chronic). |
| Interventions | Trade Name: FERINJECT 50 mg iron/ml solution for injection and infusionPharmaceutical Form: Solution for infusionINN or Proposed INN: Ferric carboxymaltoseCurrent Sponsor code: VIT-45Concentration unit: mg/ml milligram(s)/millilitre<br |
Participant Information
| Sponsor | Vifor (International) Inc. |
|---|---|
| City | NULL |
| Country/Region | Estonia;Spain;Lithuania;Denmark;Austria;Germany;United Kingdom;Sweden |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |